New composition of Ageas’s Executive Committee
Today
The changes are being implemented to:
- better reflect the current business profile taking into account the evolving importance and size of the Group’s different activities.
- simplify and improve the integration of corporate and business decision making, maximising Group synergies.
- have a dedicated focus on strategy, combined with business development opportunities.
The
The
- CEO and CFO:
Hans De Cuyper andWim Guilliams will remain Chief Executive Officer and Chief Financial Officer, respectively. - CRO:
Christophe Vandeweghe , currently CFO of Ageas Portugal, will succeedEmmanuel Van Grimbergen asChief Risk Officer as of1 June 2024 . With a career starting atING and Deloitte, Christophe joinedAgeas in 2014 as Head of Risk for Continental Europe. Since that time, he has taken up various roles at Group level. In 2018 he transferred toPortugal to become CRO for Grupo Ageas Portugal and later CFO. SinceApril 2023 he has also assumed the role of Chief Business Development Officer for the Portuguese activities. - MD
Belgium : Considering the importance ofBelgium within the Group, AG’s CEOHeidi Delobelle will join theAgeas Executive Committee as Managing Director Belgium. - MD
Europe :Ben Coumans , currently Group Director Strategy and M&A, will replaceAntonio Cano as Managing Director Europe, covering Ageas Portugal,Ageas UK and the Turkish joint ventures. - MD
Asia :Filip Coremans will continue his function as Managing Director Asia. - MD Reinsurance & Investments: Given the growth and ambitions of the reinsurance activities within the Group, the role of Managing Director Reinsurance & Investments will be created. Next to reinsurance, the scope includes Real Estate, ALM and Investments.
Emmanuel Van Grimbergen , currently CRO and with extensive experience in capital optimisation for the Group, will take up this new function as of1 June 2024 . Until then,Antonio Cano will further fulfil this position. Within this new organisationJoachim Racz will, as CEO of Ageas Re, report directly to the MD Reinsurance & Investments. - MD Business Development:
Karolien Gielen will take up the position of Managing Director Business Development. This role encompasses Strategy, M&A, Communication and the Chief Development and Sustainability Office that includes Business Development,Technology Development and Sustainability.Karolien Gielen is currently Partner and Managing Director at theBoston Consulting Group andPractice Area Lead Insurance for theLondon -Amsterdam -Brussels system.
The new Executive appointments are still subject to the approval of the
“I am convinced that the new organisation and the wealth of experience and expertise brought together in the new Executive Committee from inside and outside our Group, will help our company to grow, to innovate and to remain future proof for all our stakeholders in the near and more distant future. I would like to take this opportunity to thank
Attachment
- EN_Organisational Changes_22012024_001
![](https://ml-eu.globenewswire.com/media/ZTFjOWQ1OTAtMjU1Zi00NDU0LTgwNGYtYmM2MWM2MzAzYzI4LTEwMTQ0MTc=/tiny/Ageas.png)
© OMX, source